The rising interest in GLP-1 agonists for diabetes has generated a debate about delivery routes : transdermal systems versus tablets . Traditionally , GLP-1 treatments were solely available in tablet form, https://miriamnqpw914054.blogginaway.com/41696189/glp-1-patches-vs-tablets-is-best-for-the-patient